AMARIN CORP IS FIRST SMALL BIOPHARMACEUTICAL COMPANY TO JOIN SAFE-BIOPHARMA ASSOCIATION ›
Ft. Lee, N.J. (November 12, 2009) – Amarin Corp. (NASDAQ: AMRN), a clinical stage pharmaceutical company with R&D operations based in Mystic, Conn., has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

SAFE-BIOPHARMA RECEIVES SAFE HARBOR CERTIFICATION ›
Ft. Lee, N.J. (October 27, 2009) –SAFE-BioPharma Association has certified compliance with the US Department of Commerce and European Union Safe Harbor requirements for the protection of personal data.

SNAP DIAGNOSTICS IS FIRST DIAGNOSTICS COMPANY TO JOIN SAFE-BIOPHARMA ASSOCIATION›
Ft. Lee, N.J. (October 21, 2009) – SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

MCDOUGALL SCIENTIFIC IS FIRST CRO TO JOIN SAFE-BIOPHARMA ASSOCIATION›
Ft. Lee, N.J. (October 7, 2009) – McDougall Scientific Ltd., a Toronto based pharmaceutical contract research organization (CRO) providing the compliant technical backbone for clinical research (i.e. statistics, data management, and document management), has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software›
SUNNYVALE, Calif., September 15, 2009 – Symyx Technologies, Inc. (NASDAQ: SMMX) today announced it has joined SAFE-BioPharma Association, a non-profit association that created and manages the SAFE-BioPharma digital identity and signature standard for the pharmaceutical and healthcare industries.

SAFE-BioPharma Association Re-Certifies Adobe Software Used Throughout Pharmaceutical Industry›
FT. LEE, N.J. – June 22, 2009 -- SAFE-BioPharma Association today announced from the 45th Annual Drug Information Association (DIA) Meeting that Adobe Systems Incorporated has re-certified two software products used extensively in the pharmaceutical industry.

SAFE-BIOPHARMA CHANGES FEES TO HELP CLINICAL INVESTIGATORS, CROs, OTHERS›
Ft. Lee, NJ (June 22, 2009) -- SAFE-BioPharma Association has changed its membership fees to give clinical investigators, CROs and other smaller biopharmaceutical and healthcare entities the ability to affordably sign electronic forms, contracts and other documents digitally. The group made the announcement to coincide with the opening of the annual meeting of the Drug Information Association.

SURVEY REPORTS INCREASING USE OF SAFE-BIOPHARMA DIGITAL STANDARD›
FT. LEE, NJ (JUNE 18, 2009) — More than 20 global pharmaceutical companies, regulatory agencies, and research and group purchasing organizations are using the SAFE-BioPharma (www.safe-biopharma.org) digital standard for digitally signing electronic documents and/or managing digital identities, according to a periodic survey conducted by the standard’s organizing body.

June 23 DIA Sessions Chaired by SAFE-BioPharma Association: FDA and EMEA to Discuss eSUBMISSIONS; SAFE-BioPharma, IHE and CDISC to Discuss Role of Standards in Safety Reporting›
FT. LEE, NJ (JUNE 16, 2009) — SAFE-BioPharma Association executives will chair two sessions during the annual meeting of the Drug Information Association (DIA), June 21 – 25 in San Diego.

How Government, Industry Are Controlling Identity Management Is Subject of April 28 National Press Club Conference›
Washington, D.C. (April 6, 2009) -- How federal agencies, higher education and the aerospace and defense, and pharmaceutical and healthcare industries are using the 4BFinfrastructure (www.the4BF.com) to control identity management issues will be discussed April 28 during a two-hour seminar at the National Press Club.

Gemalto brings strong authentication to Healthcare Industry, Joins SAFE-BioPharma Association›
AUSTIN, Texas, April 6, 2009 – Gemalto, the world leader in digital security, announced today that it has become a vendor partner of SAFE-BioPharma Association (www.safe-biopharma.org). Gemalto is joining with biopharmaceutical and healthcare industry leaders to help the industry achieve its common goal of a fully electronic business environment by 2012. 

SAFE-BioPharma to Explain Interoperable Identity Management and Secure Healthcare Electronic Communications at HIMSS09 Interoperability Showcase›
FT. LEE, N.J. (April 2, 2009) – Improving interoperable identity management and secure electronic communications in the healthcare community using the SAFE-BioPharma™ digital identity and signature standard will be discussed during the annual HIMSS meeting, April 4-8, 2009 in Chicago.

Arcot Digital Signature Solution Certified Compliant with SAFE-BioPharma Digital Standard™›
Sunnyvale, California – March 25, 2009 - Arcot, leader in fraud prevention, strong authentication and e-Document security, today announced that its SignFort digital signing solution has been certified as compliant with the SAFE-BioPharma™ digital identity and signature standard. Arcot's SignFort allows electronic documents to be signed with SAFE-BioPharma digital signatures from any location without tokens, smart cards or software stored on desktops.

SAFE-BIOPHARMA NAMES GARY C. WILSON TO NEW BIOPHARMA INDUSTRY ASSOCIATION POST ›
FT. LEE, N.J. (March 18, 2009) – Gary C. Wilson has been named Technical Program Manager for SAFE-BioPharma Association (www.safe-biopharma.org), the non-profit association that created and manages the SAFE-BioPharma™ digital identity and digital signature standard for the pharmaceutical and healthcare industries.

USE OF DIGITAL SIGNATURES IN BIOPHARMACEUTICAL INDUSTRY INCREASED IN 2008 ACCORDING TO SAFE-BIOPHARMA ASSOCIATION ›
Fort Lee, N.J. (February 24, 2009) -- Identity management and use of digital signatures greatly streamlined biopharmaceutical operations in 2008 according to SAFE-BioPharma Association, the non-profit group responsible for the SAFE-BioPharma™ digital identity and signature standard used in the pharmaceutical and healthcare industries.

LIFE SCIENCES CONSULTING PARTNERS (LSCP) BECOMES SAFE-BIOPHARMA VENDOR PARTNER ›
Fort Lee, N.J. & Zurich, Switzerland (January 28, 2009) -- Life Sciences Consulting Partners (LSCP), a global consultancy providing a variety of strategic services related to International Conference on Harmonization (ICH) standards and regional regulatory authorities, has become a vendor partner of SAFE-BioPharma Association.

PHARMACEUTICAL AND HEALTH CARE EXPERTS TO DETAIL COST-CUTTING CAPABILITIES OF SECURE DIGITAL SIGNATURES ›
LOS GATOS, Calif. (Dec. 16, 2008) — TriCipher will host an informative Webinar detailing the cost cutting capabilities of digital signatures for the pharmaceutical and health care industries and strategies for securing digital signatures as more business processes transition online. The one hour webinar on December 16th brings together executives from SAFE-BioPharma Association and Pfizer who will discuss how digital signatures have benefited and streamlined research processes.

ELI LILLY AND COMPANY JOINS SAFE-BIOPHARMA ASSOCIATION ›
Ft. Lee, N.J. (December 10, 2008) – Eli Lilly and Company (NYSE: LLY), a leading innovation-driven corporation, has become a member of SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries.

JOHN HENDRIX NAMED PROGRAM DIRECTOR, MEMBER & VENDOR RELATIONS, SAFE-BIOPHARMA ASSOCIATION ›
FT. LEE, N.J. (December 4, 2008) – John Hendrix has been named Program Director, Member and Vendor Relations for SAFE-BioPharma Association, the non-profit association that created and manages the SAFE-BioPharma™ digital identity and digital signature standard for the pharmaceutical and healthcare industries.

xyzmo SIGNificant SUITE V1.6 IS NOW CERTIFIED COMPLIANT WITH SAFE-BIOPHARMA DIGITAL STANDARD ›
Jersey City, November 17, 2008 – xyzmo SIGNificant Group, the leading international digital and e-signature technology provider, announced today that its product, SIGNificant Suite, has been certified to be compliant with the SAFE-BioPharma™ digital identity and signature standard.

FOUR JOIN BOARD OF SAFE-BIOPHARMA ASSOCIATION ›
Ft. Lee, N.J. (October 28, 2008) – GlaxoSmithKline (NYSE: GSK), Merck (NYSE:MRK), Pfizer (NYSE: PFE), and Procter & Gamble (NYSE: PG) have named new representatives to the Board of Directors of SAFE BioPharma Association, the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries.

Read Previous News Releases ›